author_facet Martin, David A.
Elkon, Keith B.
Martin, David A.
Elkon, Keith B.
author Martin, David A.
Elkon, Keith B.
spellingShingle Martin, David A.
Elkon, Keith B.
Arthritis & Rheumatism
Intracellular mammalian DNA stimulates myeloid dendritic cells to produce type I interferons predominantly through a toll‐like receptor 9–independent pathway
Pharmacology (medical)
Immunology
Rheumatology
Immunology and Allergy
author_sort martin, david a.
spelling Martin, David A. Elkon, Keith B. 0004-3591 1529-0131 Wiley Pharmacology (medical) Immunology Rheumatology Immunology and Allergy http://dx.doi.org/10.1002/art.21677 <jats:title>Abstract</jats:title><jats:sec><jats:title>Objective</jats:title><jats:p>Exogenous nucleic acids, including bacterial unmethylated DNA and viral single‐stranded RNA, are potent activators of innate immunity through interaction with the Toll‐like receptors (TLRs). In contrast, mammalian DNA has been generally thought to have a limited activation effect, or even a suppressive effect, on innate immunity. Since DNA is a major component of dying cells and recent studies indicate that mammalian nucleic acids may be stimulatory under certain conditions, we undertook this study to examine the effect of intracellular mammalian DNA on myeloid dendritic cell (DC) activation.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Mammalian DNA was introduced into murine bone marrow–derived DCs (BMDCs) by transfection. BMDC activation was determined by flow cytometry (CD40, CD86). Production of tumor necrosis factor α and interleukin‐6 was measured by enzyme‐linked immunosorbent assay, and production of type I interferons (IFNs) by bioassay. Parallel studies were conducted using BMDCs from mice deficient in myeloid differentiation 88 (MyD88), TLR‐9, and IFNα/β receptor.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Intracellular mammalian DNA activated immature BMDCs, as determined by the up‐regulation of CD40 and CD86 as well as by the production of significant quantities of type I IFN. The interferogenic response was shown to be relatively independent of TLR‐9, and the TLR adaptor MyD88. The IFN response to intracellular DNA was reduced in BMDCs lacking IFNα/β receptor but was intact in embryonic fibroblasts lacking protein kinase R.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>These results indicate that intracellular DNA stimulates BMDC maturation and IFN production predominantly through a TLR‐independent pathway, and support a model whereby inefficient clearance and/or degradation of endogenous DNA may stimulate innate immune responses similar to the TLR‐independent response to exogenous (i.e., viral) double‐stranded RNA.</jats:p></jats:sec> Intracellular mammalian DNA stimulates myeloid dendritic cells to produce type I interferons predominantly through a toll‐like receptor 9–independent pathway Arthritis & Rheumatism
doi_str_mv 10.1002/art.21677
facet_avail Online
Free
finc_class_facet Chemie und Pharmazie
Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9hcnQuMjE2Nzc
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9hcnQuMjE2Nzc
institution DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
imprint Wiley, 2006
imprint_str_mv Wiley, 2006
issn 0004-3591
1529-0131
issn_str_mv 0004-3591
1529-0131
language English
mega_collection Wiley (CrossRef)
match_str martin2006intracellularmammaliandnastimulatesmyeloiddendriticcellstoproducetypeiinterferonspredominantlythroughatolllikereceptor9independentpathway
publishDateSort 2006
publisher Wiley
recordtype ai
record_format ai
series Arthritis & Rheumatism
source_id 49
title Intracellular mammalian DNA stimulates myeloid dendritic cells to produce type I interferons predominantly through a toll‐like receptor 9–independent pathway
title_unstemmed Intracellular mammalian DNA stimulates myeloid dendritic cells to produce type I interferons predominantly through a toll‐like receptor 9–independent pathway
title_full Intracellular mammalian DNA stimulates myeloid dendritic cells to produce type I interferons predominantly through a toll‐like receptor 9–independent pathway
title_fullStr Intracellular mammalian DNA stimulates myeloid dendritic cells to produce type I interferons predominantly through a toll‐like receptor 9–independent pathway
title_full_unstemmed Intracellular mammalian DNA stimulates myeloid dendritic cells to produce type I interferons predominantly through a toll‐like receptor 9–independent pathway
title_short Intracellular mammalian DNA stimulates myeloid dendritic cells to produce type I interferons predominantly through a toll‐like receptor 9–independent pathway
title_sort intracellular mammalian dna stimulates myeloid dendritic cells to produce type i interferons predominantly through a toll‐like receptor 9–independent pathway
topic Pharmacology (medical)
Immunology
Rheumatology
Immunology and Allergy
url http://dx.doi.org/10.1002/art.21677
publishDate 2006
physical 951-962
description <jats:title>Abstract</jats:title><jats:sec><jats:title>Objective</jats:title><jats:p>Exogenous nucleic acids, including bacterial unmethylated DNA and viral single‐stranded RNA, are potent activators of innate immunity through interaction with the Toll‐like receptors (TLRs). In contrast, mammalian DNA has been generally thought to have a limited activation effect, or even a suppressive effect, on innate immunity. Since DNA is a major component of dying cells and recent studies indicate that mammalian nucleic acids may be stimulatory under certain conditions, we undertook this study to examine the effect of intracellular mammalian DNA on myeloid dendritic cell (DC) activation.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Mammalian DNA was introduced into murine bone marrow–derived DCs (BMDCs) by transfection. BMDC activation was determined by flow cytometry (CD40, CD86). Production of tumor necrosis factor α and interleukin‐6 was measured by enzyme‐linked immunosorbent assay, and production of type I interferons (IFNs) by bioassay. Parallel studies were conducted using BMDCs from mice deficient in myeloid differentiation 88 (MyD88), TLR‐9, and IFNα/β receptor.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Intracellular mammalian DNA activated immature BMDCs, as determined by the up‐regulation of CD40 and CD86 as well as by the production of significant quantities of type I IFN. The interferogenic response was shown to be relatively independent of TLR‐9, and the TLR adaptor MyD88. The IFN response to intracellular DNA was reduced in BMDCs lacking IFNα/β receptor but was intact in embryonic fibroblasts lacking protein kinase R.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>These results indicate that intracellular DNA stimulates BMDC maturation and IFN production predominantly through a TLR‐independent pathway, and support a model whereby inefficient clearance and/or degradation of endogenous DNA may stimulate innate immune responses similar to the TLR‐independent response to exogenous (i.e., viral) double‐stranded RNA.</jats:p></jats:sec>
container_issue 3
container_start_page 951
container_title Arthritis & Rheumatism
container_volume 54
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792336853885517825
geogr_code not assigned
last_indexed 2024-03-01T15:07:00.512Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Intracellular+mammalian+DNA+stimulates+myeloid+dendritic+cells+to+produce+type+I+interferons+predominantly+through+a+toll%E2%80%90like+receptor+9%E2%80%93independent+pathway&rft.date=2006-03-01&genre=article&issn=1529-0131&volume=54&issue=3&spage=951&epage=962&pages=951-962&jtitle=Arthritis+%26+Rheumatism&atitle=Intracellular+mammalian+DNA+stimulates+myeloid+dendritic+cells+to+produce+type+I+interferons+predominantly+through+a+toll%E2%80%90like+receptor+9%E2%80%93independent+pathway&aulast=Elkon&aufirst=Keith+B.&rft_id=info%3Adoi%2F10.1002%2Fart.21677&rft.language%5B0%5D=eng
SOLR
_version_ 1792336853885517825
author Martin, David A., Elkon, Keith B.
author_facet Martin, David A., Elkon, Keith B., Martin, David A., Elkon, Keith B.
author_sort martin, david a.
container_issue 3
container_start_page 951
container_title Arthritis & Rheumatism
container_volume 54
description <jats:title>Abstract</jats:title><jats:sec><jats:title>Objective</jats:title><jats:p>Exogenous nucleic acids, including bacterial unmethylated DNA and viral single‐stranded RNA, are potent activators of innate immunity through interaction with the Toll‐like receptors (TLRs). In contrast, mammalian DNA has been generally thought to have a limited activation effect, or even a suppressive effect, on innate immunity. Since DNA is a major component of dying cells and recent studies indicate that mammalian nucleic acids may be stimulatory under certain conditions, we undertook this study to examine the effect of intracellular mammalian DNA on myeloid dendritic cell (DC) activation.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Mammalian DNA was introduced into murine bone marrow–derived DCs (BMDCs) by transfection. BMDC activation was determined by flow cytometry (CD40, CD86). Production of tumor necrosis factor α and interleukin‐6 was measured by enzyme‐linked immunosorbent assay, and production of type I interferons (IFNs) by bioassay. Parallel studies were conducted using BMDCs from mice deficient in myeloid differentiation 88 (MyD88), TLR‐9, and IFNα/β receptor.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Intracellular mammalian DNA activated immature BMDCs, as determined by the up‐regulation of CD40 and CD86 as well as by the production of significant quantities of type I IFN. The interferogenic response was shown to be relatively independent of TLR‐9, and the TLR adaptor MyD88. The IFN response to intracellular DNA was reduced in BMDCs lacking IFNα/β receptor but was intact in embryonic fibroblasts lacking protein kinase R.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>These results indicate that intracellular DNA stimulates BMDC maturation and IFN production predominantly through a TLR‐independent pathway, and support a model whereby inefficient clearance and/or degradation of endogenous DNA may stimulate innate immune responses similar to the TLR‐independent response to exogenous (i.e., viral) double‐stranded RNA.</jats:p></jats:sec>
doi_str_mv 10.1002/art.21677
facet_avail Online, Free
finc_class_facet Chemie und Pharmazie, Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9hcnQuMjE2Nzc
imprint Wiley, 2006
imprint_str_mv Wiley, 2006
institution DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161
issn 0004-3591, 1529-0131
issn_str_mv 0004-3591, 1529-0131
language English
last_indexed 2024-03-01T15:07:00.512Z
match_str martin2006intracellularmammaliandnastimulatesmyeloiddendriticcellstoproducetypeiinterferonspredominantlythroughatolllikereceptor9independentpathway
mega_collection Wiley (CrossRef)
physical 951-962
publishDate 2006
publishDateSort 2006
publisher Wiley
record_format ai
recordtype ai
series Arthritis & Rheumatism
source_id 49
spelling Martin, David A. Elkon, Keith B. 0004-3591 1529-0131 Wiley Pharmacology (medical) Immunology Rheumatology Immunology and Allergy http://dx.doi.org/10.1002/art.21677 <jats:title>Abstract</jats:title><jats:sec><jats:title>Objective</jats:title><jats:p>Exogenous nucleic acids, including bacterial unmethylated DNA and viral single‐stranded RNA, are potent activators of innate immunity through interaction with the Toll‐like receptors (TLRs). In contrast, mammalian DNA has been generally thought to have a limited activation effect, or even a suppressive effect, on innate immunity. Since DNA is a major component of dying cells and recent studies indicate that mammalian nucleic acids may be stimulatory under certain conditions, we undertook this study to examine the effect of intracellular mammalian DNA on myeloid dendritic cell (DC) activation.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Mammalian DNA was introduced into murine bone marrow–derived DCs (BMDCs) by transfection. BMDC activation was determined by flow cytometry (CD40, CD86). Production of tumor necrosis factor α and interleukin‐6 was measured by enzyme‐linked immunosorbent assay, and production of type I interferons (IFNs) by bioassay. Parallel studies were conducted using BMDCs from mice deficient in myeloid differentiation 88 (MyD88), TLR‐9, and IFNα/β receptor.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Intracellular mammalian DNA activated immature BMDCs, as determined by the up‐regulation of CD40 and CD86 as well as by the production of significant quantities of type I IFN. The interferogenic response was shown to be relatively independent of TLR‐9, and the TLR adaptor MyD88. The IFN response to intracellular DNA was reduced in BMDCs lacking IFNα/β receptor but was intact in embryonic fibroblasts lacking protein kinase R.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>These results indicate that intracellular DNA stimulates BMDC maturation and IFN production predominantly through a TLR‐independent pathway, and support a model whereby inefficient clearance and/or degradation of endogenous DNA may stimulate innate immune responses similar to the TLR‐independent response to exogenous (i.e., viral) double‐stranded RNA.</jats:p></jats:sec> Intracellular mammalian DNA stimulates myeloid dendritic cells to produce type I interferons predominantly through a toll‐like receptor 9–independent pathway Arthritis & Rheumatism
spellingShingle Martin, David A., Elkon, Keith B., Arthritis & Rheumatism, Intracellular mammalian DNA stimulates myeloid dendritic cells to produce type I interferons predominantly through a toll‐like receptor 9–independent pathway, Pharmacology (medical), Immunology, Rheumatology, Immunology and Allergy
title Intracellular mammalian DNA stimulates myeloid dendritic cells to produce type I interferons predominantly through a toll‐like receptor 9–independent pathway
title_full Intracellular mammalian DNA stimulates myeloid dendritic cells to produce type I interferons predominantly through a toll‐like receptor 9–independent pathway
title_fullStr Intracellular mammalian DNA stimulates myeloid dendritic cells to produce type I interferons predominantly through a toll‐like receptor 9–independent pathway
title_full_unstemmed Intracellular mammalian DNA stimulates myeloid dendritic cells to produce type I interferons predominantly through a toll‐like receptor 9–independent pathway
title_short Intracellular mammalian DNA stimulates myeloid dendritic cells to produce type I interferons predominantly through a toll‐like receptor 9–independent pathway
title_sort intracellular mammalian dna stimulates myeloid dendritic cells to produce type i interferons predominantly through a toll‐like receptor 9–independent pathway
title_unstemmed Intracellular mammalian DNA stimulates myeloid dendritic cells to produce type I interferons predominantly through a toll‐like receptor 9–independent pathway
topic Pharmacology (medical), Immunology, Rheumatology, Immunology and Allergy
url http://dx.doi.org/10.1002/art.21677